Pune, Oct. 13, 2020 (GLOBE NEWSWIRE) -- The global exosomes market is projected to witness rapid growth in the coming years driven by the massive investments in product R&D. The increasing number of clinical trials will aid the growth of the overall market in the coming years. According to a report by Fortune Business Insights, titled “Exosomes Market Size, Share & Industry Analysis, By Application (Therapeutics, Diagnostics), By Product (Instruments, Reagents, Software), By End user (Hospitals, Cancer Institutes, Others) and Regional Forecast, 2019-2026,” the market will benefit from the presence of several large scale companies that are engaged in the R&D of exosomes across the world.
Industry Developments:
March 2020: Aethlon Medical, Inc. announced its European Patent No. on Extracorporeal Removal of Microvesicular Particles. This patent is associated with the design for the depletion of immune suppressive and potentially cancer-promoting, exosomes from the circulatory system.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/exosomes-market-102780
The recent coronavirus outbreak has brought major businesses to a standstill. Due to travel bans, companies in this sector are likely to take a huge hit in the coming years. Ultimately, the rapid spread of the disease has urged governments to take strict measures. The report includes the impact on Covid-19 pandemic on the global exosomes market and discusses how major companies are coping with this.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
Exosomes are extracellular vesicles that play a huge role inn cell-to-cell communication. Recent scientific discoveries have shown that these products can play a huge role in the treatment of cancer. The massive investments in the research and development of efficient products will bode well for the growth of the overall market in the coming years. The increasing number of clinical trials associated with exosomes will create several growth opportunities for the companies operating in the market.
Click here to get the short-term and long-term impact of COVID-19 on this market.
Please visit: https://www.fortunebusinessinsights.com/exosomes-market-102780
Increasing Number of Company Mergers and Acquisitions will Bode well for Market Growth
The report encompasses several factors that have contributed to the growth of the overall market in recent years. Among all factors, the increasing number of company mergers and collaborations has had the highest impact on the growth of the market.
The increasing investment in the research and development of efficient products, coupled with the increasing government initiatives towards the development of efficient treatment method for cancer will aid growth. In March 2018, ExoDx announced that it has collaborated with Intezyne for designing and validating an exosomal RNA assay.
The company will be designing the product for use in Intezyne’s phase 1/2 clinical trials of IT-139. This product is a novel Cancer Resistance Pathway (CRP) inhibitor that is intended for the treatment of gastric, pancreatic, and a few other forms of cancer. ExoDx’s latest collaboration with Intezyne will have a huge impact on the growth of the overall exosomes market in the coming years.
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/exosomes-market-102780
North America to Emerge Dominant; Improving Healthcare Infrastructure to Aid Growth
The report analyses the latest market trends across five major regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Among all regions, the market in North America is projected to emerge dominant in the coming years.
The improving healthcare infrastructure in several countries across this region will bode well for the companies operating in the market. The increasing investments in the research and development of the product by major companies in this region will have a huge impact on the growth of the regional market.
Moreover, the high prevalence of severe types of cancer, especially in the United States will emerge in favor of market growth. The market in Europe will hold the second largest market share in the coming years driven by the increasing per capita income in several countries including Germany, France, and the UK.
List of companies profiled in the Exosomes Market report:
- ExoDx
- Hitachi Chemical Co., Ltd.
- QIAGEN
- Aethlon Medical, Inc.
- NanoSomiX
- Thermo Fisher Scientific Inc.
- Malvern Panalytical Ltd
- System Biosciences, LLC.
- Sistemic Scotland Limited
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/exosomes-market-102780
Exosomes Market Segmentations:
By Application
• Therapeutics
• Diagnostics
By Product
• Instruments
• Reagents
• Software
By End user
• Hospitals
• Cancer Institutes
• Others
By Geography
• North America (USA, Canada)
• Europe (UK, Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
• Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
• Latin America (Brazil, Mexico, Rest of Latin America)
• Middle East & Africa (South Africa, GCC, and Rest of the Middle East & Africa)
Have a Look at Related Reports:
Neurovascular Catheters Market Share & Industry Analysis, By Type (Microcatheters, Balloon Catheters, Thrombectomy Catheters, and Others), By Application (Hemorrhagic Stroke, and Ischemic Stroke), By End User (Hospitals, and Specialty Clinics), and Regional Forecast, 2019-2026
Opioid Use Disorder (OUD) Market Share & Industry Analysis, By Drug Class (Buprenorphine, Methadone, and Naltrexone), By Route of Administration (Oral, and Parenteral), By Distribution Channel (Hospital Pharmacies, Retails Pharmacies & Stores, and Online Pharmacies), and Regional Forecast, 2019-2026
Cosmetic Dentistry Market Share & Industry Analysis, By Product (Dental Systems & Equipment, Dental Implants, Dental Prosthetics, Orthodontics, Teeth Whitening, and Others), By End User (Dental Hospitals & Clinics, Dental Laboratories, and Others), and Regional Forecast, 2019-2026
Dental Prosthetics Market Share & Industry Analysis, By Type (Crowns, Bridges, Abutments, Dentures, and Others), By End User (Dental Hospitals & Clinics, Dental Laboratories, and Others), and Regional Forecast, 2019-2026
Transcatheter Heart Valve Replacement (THVR) Market Share & Industry Analysis, By Product Type (Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral Valve Replacement (TMVR), and Transcatheter Pulmonary Valve Replacement (TPVR)), By End User (Hospitals, and Specialty Clinics& Others), and Regional Forecast, 2019-2026
About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs